logo

For the Inventor, By the Inventor

Ande, France

Jérôme Emile Georges Guillemont

This inventor holds 49 USPTO granted patents and 10 published patent applications and 17 EPO patents, primarily in Antibacterial Compounds. Top assignees: Janssen Pharmaceutica Nv, Global Alliance for Tb Drug Development, Janssen Sciences Ireland Uc. Active years: 2005-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jérôme Emile Georges Guillemont. Retrieved from https://idiyas.com/inventor/jerome-emile-georges-guillemont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 49 

% Patents Active = 46.9

 

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 257(Granted Patents)


Location History:

  • Issy-les-Moulineaux, FR (2007)
  • Andre, FR (2011)
  • Val de Reuil Cedex, FR (2009 - 2015)
  • Andé, FR (2011 - 2020)
  • Val de Reuil, FR (2013 - 2020)
  • Ande, FR (2005 - 2021)

Company Filing History:

goldMedal45 out of 2,101 
 
Janssen Pharmaceutica Nv
 patents
silverMedal2 out of 10 
 
Global Alliance for Tb Drug Development
 patents
bronzeMedal2 out of 111 
 
Janssen Sciences Ireland Uc
 patents
4. 1 out of 6 
 
Elanco Animal Health Ireland Limited
 patents
5. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2005-2021

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibacterial Compounds
HIV Replication
Pyrimidines
Quinoline Derivatives
PARP Inhibitors
Mycobacterial Inhibitors
Cyclopenta[c]pyrrole
Quinazolinone Derivatives
2-Quinolinones
2-Quinoxalinones
Phenylalkyl Substituted
ADP-Ribose Polymerase
49 patents (USPTO):Explore Patents
1. 10981891 - Antibacterial compounds and uses thereof (2021-04-20),
2. 10611732 - HIV replication inhibiting pyrimidines (2020-04-07),
3. 10604523 - 1-aryl-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives (2020-03-31),
4. 10508097 - Antibacterial compounds and uses thereof (2019-12-17),
5. 10370340 - HIV replication inhibiting pyrimidines (2019-08-06),
6. 10150757 - Quinazolinone derivatives as PARP inhibitors (2018-12-11),
7. 9981919 - HIV replication inhibiting pyrimidines (2018-05-29),
8. 9617262 - Antibacterial cyclopental[C]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2017-04-11),
9. 9617244 - Antibacterial quinoline derivatives (2017-04-11),
10. 9580392 - HIV replication inhibiting pyrimidines (2017-02-28),
11. 9290493 - Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1H-[1,8]naphthyridinones (2016-03-22),
12. 9133167 - Antibacterial quinoline derivatives (2015-09-15),
13. 9115084 - 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors (2015-08-25),
14. 8841321 - Quinoline derivatives as antibacterial agents (2014-09-23),
15. 8802671 - Quinoline derivatives as antibacterial agents (2014-08-12),

Title: The Innovative Mind of Jérôme Emile Georges Guillemont

Introduction:

Jérôme Emile Georges Guillemont, a talented inventor hailing from Ande, France, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Guillemont's latest patents focus on advancements in renewable energy technologies, particularly in the development of solar-powered devices that are revolutionizing the way we harness and utilize clean energy sources.

Career Highlights:

With a career spanning over two decades, Guillemont has established himself as a visionary in the tech industry, holding numerous patents that have significantly impacted the way we interact with technology on a daily basis. His innovative spirit and dedication to pushing the boundaries of what is possible have earned him recognition as a trailblazer in his field.

Collaborations:

Throughout his career, Guillemont has collaborated with leading research institutions and tech companies to bring his inventions to life. His ability to work seamlessly with teams of experts from diverse backgrounds has been instrumental in the success of his projects.

Conclusion:

In conclusion, Jérôme Emile Georges Guillemont's passion for innovation and his relentless pursuit of technological advancement have solidified his reputation as a pioneering inventor. His contributions to the world of technology continue to inspire and shape the future of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…